Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.9091
-0.0339 (-3.59%)
Apr 16, 2026, 1:33 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 285.76K | 1.50M | 583.23K | - | - | |
Biotechnology (Startups) Growth | -80.98% | 157.63% | - | - | - | |
| 285.76K | 1.50M | 583.23K | - | - | |
| -80.98% | 157.63% | - | - | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 285.76K | 1.50M | 583.23K | - | - | |
| -80.98% | 157.63% | - | - | - | |
| 285.76K | 1.50M | 583.23K | - | - | |
| -80.98% | 157.63% | - | - | - | |
Source: S&P Global Market Intelligence.
